GABELLI & Co INVESTMENT ADVISERS, INC. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI & Co INVESTMENT ADVISERS, INC. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$75,000
-25.7%
10,0000.0%0.01%
-23.1%
Q2 2022$101,000
-18.5%
10,0000.0%0.01%
-18.8%
Q1 2022$124,000
-48.3%
10,000
-4.8%
0.02%
-50.0%
Q4 2021$240,000
+8.6%
10,500
+5.0%
0.03%
+18.5%
Q3 2021$221,000
+70.0%
10,0000.0%0.03%
+80.0%
Q2 2021$130,0000.0%10,0000.0%0.02%
-6.2%
Q1 2021$130,00010,0000.02%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders